On September 23, 2026, JPMorgan Chase & Co. disposed of 4.94 million shares of GENSCRIPT BIO (01548) off-exchange at an average of HKD 41.9651 per share, involving approximately HKD 207.17 million. The off-exchange transaction was settled in cash and did not take place on the SEHK open market, therefore it was not a direct secondary-market dealing. As a result of this disposal, JPMorgan Chase & Co. went below the 5% threshold.
Prior to the disposal, JPMorgan Chase & Co.'s long position in GENSCRIPT BIO was 115.15 million shares, representing 5.04%; following the disposal, the holding changed to 110.21 million shares, with the long position ratio falling to 4.83%.